News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
David Sher: Dosimetric advantages of online adaptive radiation therapy for head and neck squamous cell carcinoma
David Sher/utsouthwestern.edu
Apr 21, 2025, 08:59

David Sher: Dosimetric advantages of online adaptive radiation therapy for head and neck squamous cell carcinoma

ASTRO shared a post on X:

“Dosimetric advantages of online adaptive radiation therapy for head and neck squamous cell carcinoma: results from a prospective registry study by David Sher, et al.

Read about it in the Red Journal.”

David Sher: Dosimetric advantages of online adaptive radiation therapy for head and neck squamous cell carcinoma

David Sher, Medical Director of Radiation Oncology, Chief of Head and Neck Radiation Oncology Service, reshared the post on X, adding:

“In this paper, we analyzed the UTSW Radiation Oncology experience with adapt-on-demand for H&N squamous cell carcinoma using the Varian Ethos system.

TL/DR: Significant (and I think meaningful) improvement in coverage and homogeneity, but no clinically impactful reduction in OAR doses.”

Dosimetric advantages of online adaptive radiation therapy for head and neck squamous cell carcinoma: results from a prospective registry study.

Authors: Julia J. Shi, et al.

David Sher: Dosimetric advantages of online adaptive radiation therapy for head and neck squamous cell carcinoma

ASTRO cancer David Sher Dosimetric fight against cancer Global fight against cancer head and neck squamous cell carcinoma Neck Radiation Oncology OncoDaily Oncology radiation oncology radiation therapy Red Journal squamous cell carcinoma UTSW Radiation Oncology
Special Coverage
Blog
Apr 21, 2025, 15:06
Lisa Larkin: HERtalks - a new virtual series bringing clear, evidence-based info to women
Blog
Apr 21, 2025, 14:57
Douglas Flora: Unveiling a new era of AI in Precision Oncology
Insight
Apr 21, 2025, 14:55
Living with Type 2 diabetes have a significantly higher risk of developing liver and pancreatic cancers - Manchester Cancer Research Centre
Radiotherapy
Apr 21, 2025, 14:54
Brachytherapy for Prostate Cancer: Types, Success Rate, Side effects And More
Drugs
Apr 21, 2025, 14:48
Byung-June Park on triple-payload ADCs and dual-function TCE-ADCs: Breakthroughs in AACR 2025 abstracts
Blog
Apr 21, 2025, 14:44
Myriam Chalabi to present first results from NEOASIS trial on neoadjuvant BOT/BAL in MSI-H and MSS solid tumors - Agenus
Science
Apr 21, 2025, 14:27
Myeloma Paper of the Day, April 21st, suggested by Robert Orlowski
Blog
Apr 21, 2025, 14:20
Introducing AIEOP's 2024-2027 working group coordinators
Blog
Apr 21, 2025, 14:12
Regina Barragan-Carrillo supports Dr. Narjust Florez’s candidacy for IASLC Board of Directors Undesignated Board Seat #4
Blog
Apr 21, 2025, 14:11
"Efficiency Implementation in the Cancer Care Continuum" course is ready - SPCC
Blog
Apr 21, 2025, 14:09
Integrating digital pathology and genomic profiling into precision medicine - Voice of Healthcare
Societies
Apr 21, 2025, 14:08
Supreme Court Case Threatens No-Cost Mammograms: What You Need to Know About the Fight for Preventive Care